{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:40:02Z","timestamp":1737351602713,"version":"3.33.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/hco.0b013e328204c45b","type":"journal-article","created":{"date-parts":[[2007,8,7]],"date-time":"2007-08-07T07:01:35Z","timestamp":1186470095000},"page":"450-457","source":"Crossref","is-referenced-by-count":3,"title":["Novel pharmacological therapies for atrial fibrillation"],"prefix":"10.1097","volume":"22","author":[{"given":"Suveer","family":"Bagwe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marino","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Bissett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210204","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"R2-9-20210204","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"R3-9-20210204","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2006.10.062","article-title":"Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study","volume":"49","author":"Miyasaka","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R4-9-20210204","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)","volume":"48","author":"Fuster","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R5-9-20210204","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archinte.166.7.719","article-title":"Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials","volume":"166","author":"Lafuente-Lafuente","year":"2006","journal-title":"Arch Intern Med"},{"key":"R6-9-20210204","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1503\/cmaj.1031277","article-title":"Limitations to antiarrhythmic drug use in patients with atrial fibrillation","volume":"171","author":"Humphries","year":"2004","journal-title":"CMAJ"},{"key":"R7-9-20210204","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0735-1097(03)00559-X","article-title":"Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.","volume":"42","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R8-9-20210204","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation","volume":"342","author":"Roy","year":"2000","journal-title":"N Engl J Med"},{"key":"R9-9-20210204","first-page":"S2","article-title":"Mechanisms of atrial fibrillation: mother rotors or multiple daughter wavelets, or both?","volume":"9","author":"Jalife","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R10-9-20210204","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50 years on","volume":"415","author":"Nattel","year":"2002","journal-title":"Nature"},{"key":"R11-9-20210204","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Haissaguerre","year":"1998","journal-title":"N Engl J Med"},{"key":"R12-9-20210204","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/01.CIR.0000086979.39843.7B","article-title":"Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation","volume":"108","author":"Kalifa","year":"2003","journal-title":"Circulation"},{"key":"R13-9-20210204","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0008-6363(02)00258-4","article-title":"Electrical, contractile and structural remodeling during atrial fibrillation","volume":"54","author":"Allessie","year":"2002","journal-title":"Cardiovasc Res"},{"key":"R14-9-20210204","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/01.CIR.0000142052.03565.87","article-title":"Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure","volume":"110","author":"Cha","year":"2004","journal-title":"Circulation"},{"key":"R15-9-20210204","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0735-1097(99)00008-X","article-title":"Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: An insight into the mechanism of atrial electrical remodeling","volume":"33","author":"Lai","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R16-9-20210204","first-page":"e35","article-title":"Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model","volume":"96","author":"Kneller","year":"2005","journal-title":"Circ Res"},{"key":"R17-9-20210204","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1540-8167.2006.00407.x","article-title":"Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat","volume":"17","author":"Eijsbouts","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R18-9-20210204","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1568016033477441","article-title":"Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias","volume":"1","author":"Brendel","year":"2003","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"R19-9-20210204","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00395-003-0409-8","article-title":"Remodeling of cardiomyocyte ion channels in human atrial fibrillation","volume":"98","author":"Dobrev","year":"2003","journal-title":"Basic Res Cardiol"},{"key":"R20-9-20210204","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/01.CIR.0000145155.60288.71","article-title":"Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation","volume":"110","author":"Wettwer","year":"2004","journal-title":"Circulation"},{"key":"R21-9-20210204","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1161\/CIRCULATIONAHA.105.575332","article-title":"The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation","volume":"112","author":"Dobrev","year":"2005","journal-title":"Circulation"},{"key":"R22-9-20210204","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.coph.2006.09.006","article-title":"Nonion channel blockers as antiarrhythmic drugs (reversal of structural remodeling)","volume":"7","author":"Goette","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"R23-9-20210204","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2003.07.014","article-title":"Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease","volume":"42","author":"Boldt","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R24-9-20210204","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0735-1097(00)00611-2","article-title":"Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation","volume":"35","author":"Goette","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R25-9-20210204","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehi668","article-title":"Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence","volume":"27","author":"Ehrlich","year":"2006","journal-title":"Eur Heart J"},{"key":"R26-9-20210204","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jacc.2004.10.002","article-title":"Absence of acute effects of angiotensin II on atrial electrophysiology in humans","volume":"45","author":"Kistler","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R27-9-20210204","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/00005344-200112000-00002","article-title":"Electropharmacologic effects of pilsicainide, a pure sodium channel blocker, on the remodeled atrium subjected to chronic rapid pacing","volume":"38","author":"Sato","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"R28-9-20210204","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1253\/circj.70.657","article-title":"Pharmacological conversion of persistent atrial fibrillation into sinus rhythm with oral pilsicainide: pilsicainide suppression trial for persistent atrial fibrillation II","volume":"70","author":"Okishige","year":"2006","journal-title":"Circ J"},{"key":"R29-9-20210204","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0002-9149(96)00401-8","article-title":"Conversion of recent-onset Atrial Fibrillation by a single oral dose of Pilsicainide (Pilsicainide Suppression Trial on atrial fibrillation). The PSTAF Investigators","volume":"78","author":"Atarashi","year":"1996","journal-title":"Am J Cardiol"},{"issue":"Suppl III","key":"R30-9-20210204","first-page":"741","article-title":"The EURIDIS and ADONIS trials: dronedarone for maintaining sinus rhythm in patients with atrial fibrillation\/flutter [abstract]","volume":"110","author":"Singh","year":"2004","journal-title":"Circulation"},{"key":"R33-9-20210204","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00005344-200408000-00015","article-title":"In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, antiadrenergic, and antiangiotensin II effects","volume":"44","author":"Gautier","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"R34-9-20210204","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0022-3565(24)29536-7","article-title":"Structure-activity relationships and electrophysiological effects of short-acting amiodarone homologs in guinea pig isolated heart","volume":"297","author":"Morey","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"R35-9-20210204","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-3565(24)37375-6","article-title":"Differential atrial versus ventricular activities of class III potassium channel blockers","volume":"285","author":"Baskin","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"R36-9-20210204","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jacc.2004.03.047","article-title":"Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter","volume":"44","author":"Hohnloser","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R37-9-20210204","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cardiores.2006.11.024","article-title":"Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na+\/Ca2+-exchange","volume":"73","author":"Schotten","year":"2007","journal-title":"Cardiovasc Res"},{"key":"R38-9-20210204","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1540-8167.2005.50028.x","article-title":"The mechanism of atrial antiarrhythmic action of RSD1235","volume":"16","author":"Fedida","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R39-9-20210204","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2004.09.021","article-title":"A randomized, controlled trial of RSD1235, a novel antiarrhythmic agent, in the treatment of recent onset atrial fibrillation","volume":"44","author":"Roy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R40-9-20210204","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.hrthm.2005.08.011","article-title":"RSD1235 for conversion of atrial fibrillation. The Phase III Atrial Arrhythmia Conversion Trial","volume":"2","author":"Roy","year":"2005","journal-title":"Heart Rhythm"},{"key":"R41-9-20210204","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/eurheartj\/ehl209","article-title":"Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial","volume":"27","author":"Lombardi","year":"2006","journal-title":"Eur Heart J"},{"key":"R42-9-20210204","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.amjcard.2006.01.084","article-title":"Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease","volume":"98","author":"Kerr","year":"2006","journal-title":"Am J Cardiol"},{"key":"R43-9-20210204","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.0000051455.44919.73","article-title":"Asymptomatic or \u201csilent\u201d atrial fibrillation: frequency in untreated patients and patients receiving azimilide","volume":"107","author":"Page","year":"2003","journal-title":"Circulation"},{"key":"R44-9-20210204","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jacc.2006.04.075","article-title":"Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database","volume":"48","author":"Pratt","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R45-9-20210204","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0735-1097(00)00773-7","article-title":"Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators","volume":"36","author":"Pritchett","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R46-9-20210204","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.fjc.0000196242.04384.c3","article-title":"Characterization of the in vivo and in vitro electrophysiological effects of the novel antiarrhythmic agent AZD7009 in atrial and ventricular tissue of the dog","volume":"47","author":"Carlsson","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"R47-9-20210204","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.hrthm.2006.06.035","article-title":"Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009","volume":"3","author":"Crijns","year":"2006","journal-title":"Heart Rhythm"},{"key":"R48-9-20210204","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.phrs.2006.03.021","article-title":"Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective atrial effective refractory period prolongation","volume":"54","author":"Hashimoto","year":"2006","journal-title":"Pharmacol Res"},{"key":"R49-9-20210204","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/CIRCULATIONAHA.105.561738","article-title":"Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias","volume":"113","author":"Cha","year":"2006","journal-title":"Circulation"},{"key":"R50-9-20210204","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ahj.2006.01.007","article-title":"Meta-analysis: inhibition of renin\u2013angiotensin system prevents new-onset atrial fibrillation","volume":"152","author":"Anand","year":"2006","journal-title":"Am Heart J"},{"key":"R51-9-20210204","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ebm.11.1.15","article-title":"Review: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation","volume":"11","author":"Karthikeyan","year":"2006","journal-title":"Evid Based Med"},{"key":"R52-9-20210204","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejcts.2007.02.010","article-title":"Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III","volume":"31","author":"White","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"R53-9-20210204","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/01.CIR.0000022665.18619.83","article-title":"Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study","volume":"106","author":"Madrid","year":"2002","journal-title":"Circulation"},{"key":"R54-9-20210204","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/eurheartj\/ehi645","article-title":"Is atrial fibrillation an inflammatory disorder?","volume":"27","author":"Boos","year":"2006","journal-title":"Eur Heart J"},{"key":"R55-9-20210204","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1161\/hh1801.097644","article-title":"Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation","volume":"89","author":"Carnes","year":"2001","journal-title":"Circ Res"},{"key":"R56-9-20210204","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/CIRCULATIONAHA.106.621763","article-title":"Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study","volume":"114","author":"Patti","year":"2006","journal-title":"Circulation"},{"key":"R57-9-20210204","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cardiores.2005.11.028","article-title":"Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs","volume":"69","author":"Shiroshita-Takeshita","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R58-9-20210204","doi-asserted-by":"crossref","first-page":"50i","DOI":"10.1016\/j.amjcard.2005.12.027","article-title":"Antiarrhythmic effects of omega-3 fatty acids","volume":"98","author":"Reiffel","year":"2006","journal-title":"Am J Cardiol"},{"key":"R59-9-20210204","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.100.1.87","article-title":"Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort","volume":"100","author":"Li","year":"1999","journal-title":"Circulation"},{"key":"R60-9-20210204","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.106.624320","article-title":"Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure","volume":"114","author":"Lee","year":"2006","journal-title":"Circulation"},{"key":"R61-9-20210204","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.yjmcc.2006.03.005","article-title":"Identification of ischemia-regulated phosphorylation sites in connexin43: A possible target for the antiarrhythmic peptide analogue rotigaptide (ZP123)","volume":"40","author":"Axelsen","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"R62-9-20210204","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCULATIONAHA.106.665547","article-title":"Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs","volume":"115","author":"Shiroshita-Takeshita","year":"2007","journal-title":"Circulation"},{"key":"R63-9-20210204","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00018-005-5353-3","article-title":"Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation","volume":"63","author":"Bukowska","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"R64-9-20210204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.RES.83.2.117","article-title":"Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease","volume":"83","author":"Benjamin","year":"1998","journal-title":"Circ Res"},{"key":"R65-9-20210204","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1161\/01.RES.0000252323.83137.fe","article-title":"Induction of heat shock response protects the heart against atrial fibrillation","volume":"99","author":"Brundel","year":"2006","journal-title":"Circ Res"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HCO.0b013e328204c45b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:07:59Z","timestamp":1737349679000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001573-200709000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e328204c45b","relation":{},"ISSN":["0268-4705"],"issn-type":[{"type":"print","value":"0268-4705"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}